Tessy M. Goerne-Lopez

Xochimilco, DIF 04960, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Kynurenine Pathway, Nrf2 and NF-κB Cross-Regulation in the CNS: An Overview.

Kynurenine Pathway, Nrf2 and NF-κB Cross-Regulation in the CNS: An Overview.

Journal: Molecular neurobiology

Published: November 20, 2025

The Anti-proliferative Effects of Anandamide and Oleamide in Glioblastoma Cell Lines Recruit Mitochondrial and PPAR-γ Receptor Modulation.

The Anti-proliferative Effects of Anandamide and Oleamide in Glioblastoma Cell Lines Recruit Mitochondrial and PPAR-γ Receptor Modulation.

Journal: Neurochemical research

Published: November 06, 2025

Anandamide-Induced Neuroprotection of Cortical Neurons Relies on Metabolic/Redox Regulation and Mitochondrial Dynamics.

Anandamide-Induced Neuroprotection of Cortical Neurons Relies on Metabolic/Redox Regulation and Mitochondrial Dynamics.

Journal: Molecular neurobiology

Published: May 30, 2025

The Inhibition of Fatty Acid Amide Hydrolase-4 Affords Neuroprotection in a Toxic Model Induced by 6-Hydroxydopamine in Caenorhabditis elegans Nematodes.

The Inhibition of Fatty Acid Amide Hydrolase-4 Affords Neuroprotection in a Toxic Model Induced by 6-Hydroxydopamine in Caenorhabditis elegans Nematodes.

Journal: Molecular neurobiology

Published: February 25, 2025

Dopamine stabilized in ultra-nanoreservoirs for controlled delivery in parkinson's disease.

Dopamine stabilized in ultra-nanoreservoirs for controlled delivery in parkinson's disease.

Journal: Nanomedicine (London, England)

Published: February 12, 2025

S-allyl-cysteine triggers cytotoxic events in rat glioblastoma RG2 and C6 cells and improves the effect of temozolomide through the regulation of oxidative responses.

S-allyl-cysteine triggers cytotoxic events in rat glioblastoma RG2 and C6 cells and improves the effect of temozolomide through the regulation of oxidative responses.

Journal: Discover oncology

Published: April 04, 2024

Effect of catalytic nanomedicine on amputation-stage chronic venous ulcers: four case studies.

Effect of catalytic nanomedicine on amputation-stage chronic venous ulcers: four case studies.

Journal: Wound management & prevention

Published: December 13, 2023

Solid CaCO3 Formation in Glioblastoma Multiforme and its Treatment with Ultra-Nanoparticulated NPt-Bionanocatalysts.

Solid CaCO3 Formation in Glioblastoma Multiforme and its Treatment with Ultra-Nanoparticulated NPt-Bionanocatalysts.

Journal: Current cancer drug targets

Published: October 23, 2023

Catalytic Nanomedicine as a Therapeutic Approach to Brain Tumors: Main Hypotheses for Mechanisms of Action.

Catalytic Nanomedicine as a Therapeutic Approach to Brain Tumors: Main Hypotheses for Mechanisms of Action.

Journal: Nanomaterials (Basel, Switzerland)

Published: April 01, 2023

Catalytic nanomedicine: a brief review of bionanocatalysts.

Catalytic nanomedicine: a brief review of bionanocatalysts.

Journal: Nanomedicine (London, England)

Published: September 14, 2022

Catalytic Nanomedicine - A new Approach and Solution for Chronic Ulcers: Case Series.

Catalytic Nanomedicine - A new Approach and Solution for Chronic Ulcers: Case Series.

Journal: The international journal of lower extremity wounds

Published: August 09, 2022

Physicochemical properties and in vivo evaluation of Pt/TiO2-SiO2 nanopowders.

Physicochemical properties and in vivo evaluation of Pt/TiO2-SiO2 nanopowders.

Journal: Nanomedicine (London, England)

Published: October 03, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026